Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6586 stock hub

TPEX/6586 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6586is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6586

In the news

Latest news · TPEX/6586

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-11.1

P25 -16.2P50 0.3P75 9.8

ROIC-7.7

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6586 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

TWD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees Change	17%
Employees Change Percent	56.67
Enterprise value	TWD 9.6B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006586001
Last refreshed	2026-05-10
Market cap	TWD 11.7B
Price	TWD 53.8
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/6586
Website	https://www.chopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.48%
EV Earnings	-33.24x
EV/FCF	-33.37x
FCF yield	-2.47%
P/B ratio	4.74x
P/S ratio	8,165.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	74.49%
Gross Profit	TWD 1.1M
Gross Profit Growth	-35.94%
Gross Profit Growth Q	-8.39%
Gross Profit Growth3 Y	24.83%
Gross Profit Growth5 Y	78.39%
Net Income	TWD -290M
Net Income Growth Years	0%
Pretax Margin	-20,265.97%
ROA	-7.47
Roa5y	-7.79
ROCE	-13.23
ROE	-11.13
Roe5y	-12.98
ROIC	-7.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	28.12%
Cagr3y	-9.04%
Cagr5y	13.63%
EPS Growth Years	0
Revenue Growth	-60.03x
Revenue Growth Q	-34.2x
Revenue Growth Years	0x
Revenue Growth3 Y	9.77x
Revenue Growth5 Y	88.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0
Assets	TWD 2.6B
Cash	TWD 2.1B
Current Assets	TWD 2.3B
Current Liabilities	TWD 104.7M
Debt	TWD 14.6M
Debt Equity	TWD 0.01
Debt FCF	TWD -0.05
Equity	TWD 2.5B
Interest Coverage	-802.6
Liabilities	TWD 109.1M
Long Term Assets	TWD 285.2M
Long Term Liabilities	TWD 4.4M
Net Cash	TWD 2B
Net Cash By Market Cap	TWD 17.51
Net Cash Growth	-10.13%
Net Debt Equity	TWD -0.83
Tangible Book Value	TWD 2B
Tangible Book Value Per Share	TWD 9.62
WACC	7.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	19.47
Net Working Capital	TWD -30.8M
Quick ratio	18.96
Working Capital	TWD 2B
Working Capital Turnover	TWD 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	28.1%
200-day SMA	34.14
3Y total return	-24.76%
50-day SMA	35.33
50-day SMA vs 200-day SMA	50over200
5Y total return	89.44%
All Time High	251.5
All Time High Change	-78.61%
All Time High Date	2022-04-06
All Time Low	12.9
All Time Low Change	317.05%
All Time Low Date	2020-03-19
ATR	5.43
Beta	0.52
Beta1y	1.17
Beta2y	0.9
Ch YTD	91.46
High	57.8
High52	68.3
High52 Date	2026-04-16
High52ch	-21.23%
Low	52.1
Low52	22.75
Low52 Date	2026-03-10
Low52ch	136.48%
Ma50ch	52.27%
Price vs 200-day SMA	57.58%
RSI	60.44
RSI Monthly	53.97
RSI Weekly	69.62
Sharpe ratio	0.6x
Sortino ratio	1.77
Total Return	0.53%
Tr YTD	91.46
Tr1m	98.52%
Tr1w	8.47%
Tr3m	100%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -325.8M
Operating margin	-22,770.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	143,523,100%
Net Borrowing	-14,311,000
Shares Insiders	18.51%
Shares Institutions	16.84%
Shares Out	214,010,500
Shares Qo Q	0%
Shares Yo Y	-0.53%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -293.9M
Average Volume	1,313,308.7x
Bv Per Share	11.6
CAPEX	TWD -9.3M
Ch1m	98.52
Ch1w	8.47
Ch1y	28.1
Ch3m	100
Ch3y	-24.76
Ch5y	89.44
Ch6m	62.05
Change	-5.94%
Change From Open	-5.78
Close	57.2
Days Gap	-0.17
Depreciation Amortization	26,691,000
Dollar Volume	45,367,011.4
Earnings Date	2026-05-13
EBIT	TWD -325.8M
EBITDA	TWD -299.2M
EPS	TWD -1.36
F Score	2
FCF	TWD -288.9M
FCF EV Yield	-3x
FCF Per Share	TWD -1.35
Financing CF	-14,311,000
Fiscal Year End	December
Founded	2,012
Investing CF	324,187,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-06-30
Ma150	32.56
Ma150ch	65.23%
Ma20	49.57
Ma20ch	8.54%
Net CF	30,277,000
Next Earnings Date	2026-05-13
Open	57.1
Position In Range	29.82
Ppne	30,266,000
Price Date	2026-05-08
Ptbv Ratio	5.72
Relative Volume	0.65x
Revenue	1,431,000x
SBC By Revenue	351.85x
Share Based Comp	5,035,000
Tr6m	62.05%
Volume	843,253

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6586 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6586 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6586?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.8%

Share of float held by funds and institutions

Insider ownership

+18.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.5%

Negative means the company is buying back shares.

Technical

TPEX/6586 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.4

Neutral momentum band

Price vs 200-day MA

+57.6%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

0.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6586

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6586 stock rating?

tpex/6586 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6586 analysis?

The full report lives at /stocks/tpex/6586/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6586?

The latest report frames tpex/6586 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6586 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.